FDW028
Based on 2 publication(s) in Google Scholar
FDW028 a potent and highly selective FUT8 inhibitor. FUT8 exhibits potent anti-tumor activity by defucosylation and impelling lysosomal degradation of B7-H3 through the chaperone-mediated autophagy (CMA) pathway. FDW028 can be used for metastatic colorectal cancer (mCRC) research.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza: 99.41%
- No. CAS: 2768426-49-7
- Fòrmula: C22H24N6O
- Peso molecular:388.47
-
Almacenamiento:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Publications Citing Use of MedChemExpress (MCE) FDW028
More
Actividad biológica
FDW028 (50 μM, 72 hours) promotes defucosylation and lysosomal degradation of B7-H3 and inhibits the AKT/MTOR pathway[1]. FDW028 (50 μM, 72 hours) promotes B7-H3 and LAMP1 colocalization, facilitating lysosomal degradation of B7-H3[1]. FDW028 (0.2–100 μM, 72 hours) significantly inhibits proliferation of SW480 and HCT-8 cells with IC50 values of 5.95 μM and 23.78 μM[1]. FDW028 (50 μM, 72 hours) significantly inhibits migration in SW480 and HCT-8 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:SW480 cells, HCT-8 cells
-
Concentration:0.2–100 μM
-
Incubation Time:72 h
-
Result:Promoted the colocalization of B7-H3 and LAMP1 in lysosomes.
-
Cell Line:SW480 cells, HCT-8 cells
-
Concentration:50 μM
-
Incubation Time:72 h
-
Result:Inhibited cell proliferation, with IC50 values of 5.95 μM and 23.78 μM for SW480 and HCT-8, respectively.
-
Cell Line:SW480 cells, HCT-8 cells
-
Concentration:50 μM
-
Incubation Time:72 h
-
Result:Promoted defucosylation of B7-H3, facilitated lysosomal degradation, and inhibited the AKT/MTOR pathway.
-
Cell Line:SW480 cells, HCT-8 cells
-
Concentration:50 μM
-
Incubation Time:72 h
-
Result:Inhibited the migration ability of SW480 and HCT-8 cells.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Colorectal cancer cell line SW480 xenograft mouse model (C57BL/6 mice, 4-6 weeks)[1]
-
Dosage:10 mg/kg, 20 mg/kg
-
Administration:Intravenous injection (i.v.), every other day, tumor size and body weight were measured every other day during the experiment
-
Result:Inhibited tumor growth, comparable to 5-Fu (HY-90006), and did not cause significant weight loss.
-
Animal Model:Mc38 colorectal cancer pulmonary metastasis mouse model (C57BL/6 mice, 4-6 weeks)[1]
-
Dosage:20 mg/kg
-
Administration:Intravenous injection (i.v.), every other day, were measured every other day during the experiment
-
Result:Significantly prolonged the survival of tumor-bearing mice.
Chemical Information
-
No. CAS 2768426-49-7
-
Appearance Solid
-
Peso molecular 388.47
-
Fòrmula C22H24N6O
-
Color White to off-white
-
SMILES
OC1=CC(CNCC2=CC=CC=C2)=NC3=NC(NCC4=CC=C(CC)C=C4)=NN31
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
Int J Biol Macromol
Genome-wide CRISPR screen identifies ALG5, ALG6, NF2, and FUT8 as key host proteins involved in transmissible gastroenteritis virus infection. [Abstract]2025 Dec;333(Pt 2):148770. PMID: 41205942 -
PLoS Pathog
FUT8-mediated core fucosylation of receptor APN drives entry of multiple alphacoronaviruses. [Abstract]2026 May 18;22(5):e1014227. PMID: 42149951
Solvente y solubilidad
DMSO : 100 mg/mL (257.42 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pureza y Documentación
-
Ficha de datos (275 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.5742 mL | 12.8710 mL | 25.7420 mL | 64.3550 mL |
| 5 mM | 0.5148 mL | 2.5742 mL | 5.1484 mL | 12.8710 mL | |
| 10 mM | 0.2574 mL | 1.2871 mL | 2.5742 mL | 6.4355 mL | |
| 15 mM | 0.1716 mL | 0.8581 mL | 1.7161 mL | 4.2903 mL | |
| 20 mM | 0.1287 mL | 0.6436 mL | 1.2871 mL | 3.2178 mL | |
| 25 mM | 0.1030 mL | 0.5148 mL | 1.0297 mL | 2.5742 mL | |
| 30 mM | 0.0858 mL | 0.4290 mL | 0.8581 mL | 2.1452 mL | |
| 40 mM | 0.0644 mL | 0.3218 mL | 0.6436 mL | 1.6089 mL | |
| 50 mM | 0.0515 mL | 0.2574 mL | 0.5148 mL | 1.2871 mL | |
| 60 mM | 0.0429 mL | 0.2145 mL | 0.4290 mL | 1.0726 mL | |
| 80 mM | 0.0322 mL | 0.1609 mL | 0.3218 mL | 0.8044 mL | |
| 100 mM | 0.0257 mL | 0.1287 mL | 0.2574 mL | 0.6436 mL |